StockNews.com Initiates Coverage on Onconova Therapeutics (NASDAQ:ONTX)

StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research note published on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a buy rating and set a $11.00 price objective on shares of Onconova Therapeutics in a research report on Thursday, October […]

Leave a Reply

Your email address will not be published.

Previous post Old Point Financial (NASDAQ:OPOF) Research Coverage Started at StockNews.com
Next post Children’s Place (NASDAQ:PLCE) Lifted to Hold at StockNews.com